Literature DB >> 23111105

Intraosseous inoculation of tumor cells into bone marrow promotes distant metastatic tumor development: A novel tool for mechanistic and therapeutic studies.

Jeffry Cutrera1, Blake Johnson, Lee Ellis, Shulin Li.   

Abstract

Bone marrow-derived cells have a potent impact on the formation and progression of tumor metastasis. This study demonstrates that bone marrow directly promotes metastasis to distant sites from tumor cells residing in the bone marrow in multiple types of tumors and multiple mouse strains. The bone marrow environment requires less tumor cells for inducing distant metastasis and overcomes the inhibition of metastasis resulting from engineering the tumor cells with reporter genes. This discovery provides an effective approach to generate spontaneous-like metastatic tumor models which will satisfy the urgent need for studying metastasis biology and discovering novel therapeutics.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23111105      PMCID: PMC3535523          DOI: 10.1016/j.canlet.2012.10.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

1.  Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.

Authors:  Ronald J Messer; Ulf Dittmer; Karin E Peterson; Kim J Hasenkrug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

2.  Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo.

Authors:  Wei Zhu; Wenrong Xu; Runqiu Jiang; Hui Qian; Miao Chen; Jiabo Hu; Weike Cao; Chongxu Han; Yongchang Chen
Journal:  Exp Mol Pathol       Date:  2005-10-07       Impact factor: 3.362

3.  Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis.

Authors:  Patricia Amé-Thomas; Hélène Maby-El Hajjami; Céline Monvoisin; Rachel Jean; Delphine Monnier; Sylvie Caulet-Maugendre; Thierry Guillaudeux; Thierry Lamy; Thierry Fest; Karin Tarte
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

Review 4.  The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells.

Authors:  Bong Ihn Koh; Yibin Kang
Journal:  EMBO Rep       Date:  2012-05       Impact factor: 8.807

Review 5.  Niche-to-niche migration of bone-marrow-derived cells.

Authors:  Rosandra N Kaplan; Bethan Psaila; David Lyden
Journal:  Trends Mol Med       Date:  2007-01-02       Impact factor: 11.951

Review 6.  Bone marrow cells in the 'pre-metastatic niche': within bone and beyond.

Authors:  Rosandra N Kaplan; Bethan Psaila; David Lyden
Journal:  Cancer Metastasis Rev       Date:  2006-12       Impact factor: 9.264

Review 7.  WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies.

Authors:  C Rosenfeld; M A Cheever; A Gaiger
Journal:  Leukemia       Date:  2003-07       Impact factor: 11.528

8.  Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors.

Authors:  Ryan M Teague; Blythe D Sather; Jilian A Sacks; Maria Z Huang; Michelle L Dossett; Junko Morimoto; Xiaoxio Tan; Susan E Sutton; Michael P Cooke; Claes Ohlén; Philip D Greenberg
Journal:  Nat Med       Date:  2006-02-12       Impact factor: 53.440

9.  Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals.

Authors:  Linhua Zou; Brian Barnett; Hana Safah; Vincent F Larussa; Melina Evdemon-Hogan; Peter Mottram; Shuang Wei; Odile David; Tyler J Curiel; Weiping Zou
Journal:  Cancer Res       Date:  2004-11-15       Impact factor: 12.701

10.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.

Authors:  Rosandra N Kaplan; Rebecca D Riba; Stergios Zacharoulis; Anna H Bramley; Loïc Vincent; Carla Costa; Daniel D MacDonald; David K Jin; Koji Shido; Scott A Kerns; Zhenping Zhu; Daniel Hicklin; Yan Wu; Jeffrey L Port; Nasser Altorki; Elisa R Port; Davide Ruggero; Sergey V Shmelkov; Kristian K Jensen; Shahin Rafii; David Lyden
Journal:  Nature       Date:  2005-12-08       Impact factor: 49.962

View more
  3 in total

1.  Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo.

Authors:  Denada Dibra; Abhisek Mitra; Melisa Newman; Xueqing Xia; Jeffry J Cutrera; Mihai Gagea; Eugenie S Kleinerman; Guillermina Lozano; Shulin Li
Journal:  Clin Cancer Res       Date:  2016-03-15       Impact factor: 12.531

2.  RGS12 inhibits the progression and metastasis of multiple myeloma by driving M1 macrophage polarization and activation in the bone marrow microenvironment.

Authors:  Gongsheng Yuan; Yan Huang; Shu-Ting Yang; Andrew Ng; Shuying Yang
Journal:  Cancer Commun (Lond)       Date:  2021-12-20

3.  Intricacies for posttranslational tumor-targeted cytokine gene therapy.

Authors:  Jeffry Cutrera; Denada Dibra; Arun Satelli; Xuexing Xia; Shulin Li
Journal:  Mediators Inflamm       Date:  2013-11-27       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.